Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Anne M. Gehrels

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6966-2356; OpenAlex author ID A5109638353. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 7

  1. The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
  2. Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trial. Co-author DOI 10.1016/j.ejca.2026.116683↗
  3. Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. Co-author DOI 10.1097/j.pain.0000000000004059↗
  4. Survival scenarios of patients with localized and metastatic pancreatic adenocarcinoma: A population-based study. First author DOI 10.1002/ijc.35267↗
  5. Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort study. Co-author DOI 10.1016/j.eclinm.2024.103068↗
  6. Gender differences in tumor characteristics, treatment allocation and survival in stage I-III pancreatic cancer: a nationwide study. Co-author DOI 10.1016/j.ejca.2024.114117↗
  7. Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1093/bjs/znae244↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Johanna W. Wilmink · 6 shared papers, 2024–2026 · strength 1.35
  2. Marc G. Besselink · 5 shared papers, 2024–2026 · strength 1.08
  3. Judith de Vos‐Geelen · 4 shared papers, 2025–2026 · strength 0.95
  4. Hanneke W.M. van Laarhoven · 4 shared papers, 2024–2026 · strength 0.90
  5. Lydia G. van der Geest · 3 shared papers, 2024–2025 · strength 0.66
  6. Marjolein Y.V. Homs · 3 shared papers, 2024–2026 · strength 0.63
  7. Esther N. Pijnappel · 2 shared papers, 2025–2026 · strength 0.48
  8. Pauline A. J. Vissers · 2 shared papers, 2025–2026 · strength 0.45
  9. Martijn W.J. Stommel · 2 shared papers, 2025 · strength 0.44
  10. Casper H.J. van Eijck · 2 shared papers, 2024 · strength 0.40
  11. Bas Groot Koerkamp · 2 shared papers, 2024–2025 · strength 0.40
  12. Simona Casalino · 1 shared paper, 2026 · strength 0.27
  13. Davide Melisi · 1 shared paper, 2026 · strength 0.27
  14. Gerald W. Prager · 1 shared paper, 2026 · strength 0.27
  15. Teresa Mercade Macarulla · 1 shared paper, 2026 · strength 0.27
  16. Simone Augustinus · 1 shared paper, 2026 · strength 0.24
  17. Merlijn U.J.E. Graus · 1 shared paper, 2026 · strength 0.24
  18. Stefan A.W. Bouwense · 1 shared paper, 2026 · strength 0.24
  19. Nigel G. Kooreman · 1 shared paper, 2026 · strength 0.24
  20. Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.24
  21. Steven C. Kuijper · 1 shared paper, 2025 · strength 0.22
  22. Izaak Quintus Molenaar · 1 shared paper, 2025 · strength 0.22
  23. Vincent Erwin de Meijer · 1 shared paper, 2025 · strength 0.22
  24. Lois A. Daamen · 1 shared paper, 2025 · strength 0.21
  25. Esther N. Dekker · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.